Hiroaki Uranishi
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions 3
- Cancer Research top 10%
- NF-κB Signaling Pathways 6
- Oncology top 10%
-
- RNA Research and Splicing 6
- RNA regulation and disease 5
- Nuclear Structure and Function 3
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes 3
-
- Pharmacy and Medical Practices 3
-
- T-cell and Retrovirus Studies 2
- Co-authors
- Toshifumi TetsukaTakashi OkamotoKaori AsamitsuNaoko TakahashiLijin FengTongxiang LinWei GuYang Xu
- Cited by
- ToxicologyCancer ResearchOncology
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (5 papers)PLoS ONE (1 paper)
- Partner nations
- JapanUnited StatesPoland
In The Last Decade
Hiroaki Uranishi
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 104
- Toxicology 42
- Cancer Research 184
- Oncology 273
- Molecular Biology 671
- Geriatrics and Gerontology 36
Countries citing papers authored by Hiroaki Uranishi
This map shows the geographic impact of Hiroaki Uranishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Uranishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Uranishi more than expected).
Fields of papers citing papers by Hiroaki Uranishi
This network shows the impact of papers produced by Hiroaki Uranishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Uranishi. The network helps show where Hiroaki Uranishi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroaki Uranishi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 7 | |
| 2 | 2019 | 11 | |
| 3 | 2018 | 8 | |
| 4 | 2017 | 29 | |
| 5 | 2015 | 54 | |
| 6 | 2012 | 13 | |
| 7 | 2011 | 13 | |
| 8 | 2010 | 11 | |
| 9 | 2010 | 24 | |
| 10 | 2010 | 40 | |
| 11 | 2009 | 41 | |
| 12 | 2009 | 51 | |
| 13 | 2008 | 7 | |
| 14 | 2006 | 49 | |
| 15 | 2005 | 193 | |
| 16 | 2004 | 75 | |
| 17 | 2004 | 7 | |
| 18 | 2002 | 149 | |
| 19 | 2001 | 134 | |
| 20 | 2000 | 83 |
About Hiroaki Uranishi
Hiroaki Uranishi is a scholar working on Toxicology, Geriatrics and Gerontology and Family Practice, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (6 papers), RNA Research and Splicing (6 papers), RNA regulation and disease (5 papers), Pharmacy and Medical Practices (3 papers), Nuclear Structure and Function (3 papers), Pharmaceutical Practices and Patient Outcomes (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Toxicology (42 citations), Cancer Research (184 citations) and Oncology (273 citations). Hiroaki Uranishi has collaborated with scholars based in Japan, United States and Poland. Frequent co-authors include Toshifumi Tetsuka, Takashi Okamoto, Kaori Asamitsu, Naoko Takahashi, Lijin Feng, Tongxiang Lin, Wei Gu, Yang Xu, Jenifer Bear and Barbara K. Felber. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.